Ads
related to: teva pharmaceuticals
Search results
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoTeva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript May 8, 2024 Teva...
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
InvestorPlace· 1 hour agoSeveral drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical...
Piper Sandler bullish on Teva stock on solid pipeline By Investing.com
Investing.com· 3 days agoOn Monday, Piper Sandler confirmed its Overweight rating on Teva Pharmaceutical Industries Limited...
Teva executive sells over $250k in company stock By Investing.com
Investing.com· 23 hours agoVikki L. Conway, acting Head of Global Human Resources at Teva Pharmaceutical Industries Ltd. (NYSE:...
Teva Pharmaceutical Industries (NYSE:TEVA) Downgraded to Buy at StockNews.com
ETF DAILY NEWS· 2 days agoBarclays lifted their price target on shares of Teva Pharmaceutical Industries from $17.00 to $20.00 and gave the stock an overweight rating in a report ...
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 7 days agoTEVA reports mixed first-quarter results, missing estimates for earnings but beating the same for...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters· 7 days ago, opens new tab blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months of 2024. In the wake of February's U.S. Food and Drug Administration ...
Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?
Zacks· 3 days agoWhile the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies ...
Teva Pharmaceutical Industries First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 7 days agoTeva Pharmaceutical Industries (NYSE:TEVA) First Quarter 2024 Results Key Financial Results Revenue:...
David Abrams Exits Teva Pharmaceutical in Q1 2024, Reflecting Strategic Portfolio Adjustments
GuruFocus.com via Yahoo Finance· 2 days agoThe first quarter of 2024 has seen significant shifts in his investment strategy, particularly with...